STEMI Watch 2024: Advancing Developments, Improving Outcomes
Price: $199.00
Product Details
Written with Mission: Lifeline® hospitals in mind, STEMI Watch 2024: Advancing Developments, Improving Outcomes provides physicians and staff with a concise and practical update on ST-segment elevation myocardial infarction (STEMI). In the eighth edition of this series, you'll gain valuable STEMI CME/CE while reviewing clinically relevant recommendations to improve consistency of cardiac care for patients.
Complete with tables, treatment algorithms, and ECG strips, STEMI 2024 is presented in five online modules allowing for per-module CME/CE testing. Gain insight on STEMI diagnosis, treatment, and management; ECG analysis and review; tachycardia in the emergency department.
In the United States, someone has a heart attack every 40 seconds, and someone dies from heart disease every 33 seconds. STEMI 2024 provides tools to help you and your staff make positive changes.
Features:
- Expertly written articles on evidence-based treatments for STEMI
- Valuable ECG images with interpretation from experts
- Concise targeted articles that summarize the latest research and provide clinically relevant recommendations to improve patient care
- Opportunity to earn up to 10 AMA PRA Category 1 Credits™ or ANCC credits
Benefits include:
- Improve the consistency of cardiac care for STEMI patients.
- Gain proven strategies to eliminate obstacles that prevent STEMI patients from accessing and receiving appropriate treatments.
- Easy module format for physicians and nurses to earn self-paced continuing education credits.
- Concise PDF format for convenient offline learning.
Table of Contents
Module 1: Evaluation, Diagnosis, and Initial Therapy
Module 2: ECG Analysis and Review
Module 3: Treatment and Management
Module 4: Tachycardia in the Emergency Department: Part I
Module 5: Tachycardia in the Emergency Department: Part II
Contact us for custom reprints and group sales opportunities.
Faculty:
Physician Editor:
Michael H. Crawford, MD
Professor of Medicine, Lucy Stern Chair in Cardiology, Division of Cardiology, University of California, San Francisco
Physician Peer Reviewers:
Elaine Chen, MD
Assistant Professor, Department of Internal Medicine, Division of Pulmonary and Critical Care Medicine, Section of Palliative Medicine, Rush University Medical Center, Chicago
Susan Zhao, MD
Director, Adult Echocardiography Laboratory, Associate Chief, Division of Cardiology, Department of Medicine, Santa Clara Valley Medical Center, San Jose, CA
Frank LoVecchio, DO, FACEP
Vice-Chair for Research, Medical Director, Samaritan Regional Poison Control Center, Emergency Medicine Department, Maricopa Medical Center, Phoenix, AZ
Nurse Planners:
Maureen Archambault, RN, MBA, HRM, CPHRM, FASHRM
Director, Risk Management and Patient Safety, Community Memorial Health System, Ventura, CA
Kay Ball, PhD, RN, CNOR, CMLSO, FAAN
Consultant/Educator, Adjunct Professor, Nursing, Otterbein University, Westerville, OH
Andrea Light, MS, BSN, RN, EMT, TCRN, CEN
Trauma Program Manager, Mt. Carmel East, Columbus, OH
Theresa Lombardo, DNP, APRN-CNP
Lead Advanced Practice Provider, MICU and Inpatient Lung Transplant, Division of Pulmonary and Critical Care, Northwestern Memorial Hospital, Chicago
Aurelia Macabasco-O’Connell, PhD, ACNP-BC, RN, PHN, FAHA
Associate Professor, Azusa Pacific University School of Nursing, Azusa, CA
Susan Solverson, BSN, RN, CMSRN
Grafton, WI
Accreditation & Credit Designation Statements:
In support of improving patient care, Relias LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
The Relias LLC designates this enduring material for a maximum of 10 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
10 ANCC contact hours will be awarded to participants who meet the criteria for successful completion.
Activity Objectives:
After reading STEMI Watch 2024: Advancing Developments, Improving Outcomes, the participant will be able to:
- Discuss current scientific research and data regarding the diagnosis of ST-segment elevation myocardial infarction (STEMI).
- Discuss the pathogenesis and treatment of STEMI.
- Cite new information regarding new drugs for STEMI and new uses for traditional drugs.
- Identify ancillary issues of importance for healthcare providers who treat STEMI patients.
- Discuss advances in STEMI treatment.
How to Earn Credits:
Physicians and nurses participate in this CME/CE activity by reading the articles, using the provided references for further research, and studying the relevant questions at the end each module Participants will then be directed to a website, where they will complete an online assessment to show what they’ve learned. They must score 80% on the assessment to complete the activity, but they are allowed to answer the questions multiple times if needed. After they have successfully completed the assessment, they will be directed to an online activity evaluation form. Once that is submitted, they will receive their credit letter.
Target Audience:
This activity is intended for cardiologists, coronary care nurses and staff, emergency medicine physicians and nurses, emergency medical service providers, ECG staff, percutaneous coronary intervention center staff, and freestanding emergency department staff.
Expiration: July 15, 2027
ISBN: 978-1-941481-74-5
Price: $199.00